C11orf31-CTNND1 readthrough (ENSG00000254732)

The C11orf31-CTNND1 readthrough is a fusion transcript that encompasses the C11orf31 (Chromosome 11 Open Reading Frame 31) gene and the CTNND1 (Catenin delta-1) gene. Such readthroughs generally occur as a result of transcription extending beyond the normal stop site of one gene and continuing into a neighboring gene. Evidence suggests that this particular readthrough is an NMD (nonsense-mediated decay) candidate, meaning that the resulting RNA is likely degraded and does not produce a functional protein[1][3]. There are no annotated protein products or known functional roles for this transcript, and related databases indicate no transcripts associated with C11orf31[5]. There are no literature reports supporting biological activity, disease association, or druggability for this entity. The lack of transcripts and protein products, along with its identification as an NMD candidate, strongly suggests that this is not a valid drug target or receptor. Current databases do not list drugs, known mechanisms, disease roles, or biomarker functions for this locus. There is nothing inherently pathological about cataloging readthrough loci, but they often do not represent functional proteins and should not be confused with legitimate therapeutic targets. This entry appears to be the result of automated genome annotation or bioinformatic prediction and is not recognized as a functional protein or a therapeutic target in standard biomedical databases.

Other names

C11orf31-CTNND1 fusionC11orf31-CTNND1 chimeric transcript